GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (ASX:IPD) » Definitions » YoY Rev. per Sh. Growth

Impedimed (ASX:IPD) YoY Rev. per Sh. Growth : -60.00% (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Impedimed YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Impedimed's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was -60.00%.

Impedimed's Revenue per Share for the six months ended in Dec. 2023 was A$0.00.


Impedimed YoY Rev. per Sh. Growth Historical Data

The historical data trend for Impedimed's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed YoY Rev. per Sh. Growth Chart

Impedimed Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.67 - -30.00 -14.29 -

Impedimed Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -25.00 66.67 -33.33 -60.00

Impedimed YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Impedimed's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2023 )
=(Revenue per Share (A: Jun. 2023 )-Revenue per Share (A: Jun. 2022 ))/ | Revenue per Share (A: Jun. 2022 ) |
=(0.006-0.006)/ | 0.006 |
=0.00 %

Impedimed's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(0.002-0.005)/ | 0.005 |
=-60.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Impedimed YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Impedimed's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Impedimed (ASX:IPD) Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The Company recognizes revenue from stand alone sale of Legacy Devices and Consumables, Sale of SOZO Device and Software Subscription Services.

Impedimed (ASX:IPD) Headlines

No Headlines